Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0351219930250020139
Korean Journal of Infectious Diseases
1993 Volume.25 No. 2 p.139 ~ p.149
CD4+ T Lymphocyte, beta2-microglobulin and p24 antigen Level in HIV Infected Persons
Á¶¿µ°É
ÃÖº´¼±/±è¿µºÀ/Á¶±ºÁ¦/°­ Ãá/±è¼º¼ø/±â¹Ì°æ/Çã¼÷Áø/±èż÷
Abstract
We have measured CD4+T lymphocyte, ¥â2-microglobulin (¥â2-MG) and p24 antigen level in 188 HIV patients. Estimated duration from presumptive HIV infection to last tested CD4+T lymphocyte counting was 55.2*23 months in group with Zidovudine
(Acidothymidine, AZT) treatment (Tx) and 38.4*20 months in group without AZT. There was no CD4+T lymphocyte of less than 400/mm* in 188 HIV patients. Annual decrease of CD4+T lymphocyte counts was 70/mm* in group without AZT tx and 38/mm* in
group
with
AZT tx 15.2 months after tx start. In the distribution of serum ¥â2-MG level in 182 HIV patients and 48 normal control. 90% (43) of control were below 2.0mg/L and 76% (139) of HIV patients were over 2.0mg/L (P=0). ¥â2-MG level was negatively
correlated
with CD4+T lymphocyte (r=-0.394, p<0.001). HIV p24 core antigen was detected in 26 (14.9%) out of 174 HIV/AIDS patients. Of the 26 patients, 21 (81%) were CD4+T lymphocyte of less than 400/mm* and 46% (12) of less than 200/mm*. It was confirmed
that 3
tests mentioned above are useful markers for prognosis of HIV infected persons.
KEYWORD
FullTexts / Linksout information
Listed journal information
´ëÇÑÀÇÇÐȸ ȸ¿ø